Document Classification

Section Type: RESULTS

Text: In comparison with the baseline, both the monotherapy group and the combination therapy group showed significant decreased in the IPSS (16. 50 + / - 4. 27 vs 13. 68 + / - 3. 69 and 15. 51 + / - 3. 80 vs 11. 49 + / - 2. 75), urine storage symptom score (10. 48 + / - 2. 75 vs 7. 98 + / - 2. 34 and 9. 47 + / - 2. 31 vs 5. 74 + / - 1. 66), OABS (8. 55 + / - 2. 69 vs 6. 32 + / - 1. 97 and 8. 21 + / - 2. 55 vs 4. 44 + / - 1. 62), urgent micturition score (4. 25 + / - 1. 06 vs 3. 23 + / - 0. 99 and 4. 07 + / - 0. 83 vs 2. 26 + / - 1. 05), QOL (5. 36 + / - 0. 72 vs 3. 43 + / - 0. 66 and 5. 07 + / - 0. 86 vs 2. 37 + / - 0. 76) and PVR ([44. 55 + / - 22. 39] vs [38. 30 + / - 20. 20] ml and [36. 19 + / - 21. 21] vs [24. 98 + / - 17. 60] ml) (P < 0. 01).